Propionic Acid

Propionic Acid

SCHEMBL4162291

CC(C)(O)C#Cc1ccc2[nH]c(=O)c3[nH]ccc3c2c1.CCC(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.39
GABRA1 P14867 4/20 0.38
GABRG2 P18507 4/20 0.38
GABRB3 P28472 4/20 0.38
GABRA3 P34903 4/20 0.38
GABRA2 P47869 4/20 0.38
PIKFYVE Q9Y2I7 6/20 0.37
TTBK1 Q5TCY1 3/20 0.37
PTGES O14684 2/20 0.35
MAP3K14 Q99558 3/20 0.35
PAK4 O96013 1/20 0.35
PRKX P51817 1/20 0.35
TAOK1 Q7L7X3 1/20 0.35
TSSK3 Q96PN8 1/20 0.35
TSSK1B Q9BXA7 1/20 0.35
TAOK3 Q9H2K8 1/20 0.35
PAK6 Q9NQU5 1/20 0.35
PAK5 Q9P286 1/20 0.35
TAOK2 Q9UL54 1/20 0.35
ALK Q9UM73 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4160296 0.86 GRM5 (0.44) GABRA1GABRG2GABRB3GABRA3GABRA2
Propionic Acid SCHEMBL4160262 0.84 GABRA1 (0.48) GABRA1GABRG2GABRB3GABRA3GABRA2
Propionic Acid SCHEMBL4165408 0.83 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRA3GABRA2
Propionic Acid SCHEMBL4155568 0.82 PIM1 (0.41) GABRA1GABRG2GABRB3GABRA3GABRA2
Propionic Acid SCHEMBL4159523 0.79 FFAR1 (0.43) GABRA1GABRG2GABRB3GABRA3GABRA2
Propionic Acid SCHEMBL4155220 0.78 FASN (0.41)
Propionic Acid SCHEMBL4162421 0.78 KDM4E (0.40) GABRA1PTGESTBXAS1
Propionic Acid SCHEMBL4160624 0.77 MPO (0.43) GABRA1GABRG2GABRB3GABRA3GABRA2
Propionic Acid SCHEMBL4165125 0.77 PARP1 (0.47)
Propionic Acid SCHEMBL4169911 0.77 GABRA1 (0.41) GABRA1GABRG2GABRB3GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PDE2A 983/4885GABRA1 3395/4885GABRG2 2327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.